AZD-5991
AZD-5991 is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay[1].
Product Specifications
CAS Number
[2143061-81-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD-5991.html
Purity
99.79
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)C1=C(CCCOC2=C(C=CC=C3)C3=CC4=C2)C5=C(N1C)C(C6=C(C)N(C)N=C6CSCC7=NN(C)C(CS4)=C7)=C(Cl)C=C5
Molecular Formula
C35H34ClN5O3S2
Molecular Weight
672.26
Precautions
H302, H315, H319, H335
References & Citations
[1]Tron AE, et al. Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia. Nat Commun. 2018 Dec 17;9 (1) :5341.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Mcl-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
251764-PE 100 µL
SLC9A9 (Solute Carrier Family 9 (Sodium/hydrogen Exchanger), Member 9, FLJ35613, NHE9, Nbla00118) (PE)
Ask
View Details 
